Episode 157: March Retinal Physician Review with Dr. Shriji Patel including discussion of complement inhibition for AMD, faricimab, brolucizimab, and prefilled syringes for injectable medications

Dr. Shriji Patel from Vanderbilt University joins the show to preview the March 2019 issue of Retinal Physician, including discussion of complement inhibition for AMD, new agents such as faricimab and brolucizimab, and prefilled syringes for injectable medications. All articles can be found online at retinalphysician.com.

Financial Disclosures:
Dr. Patel has no disclosures. Dr. Sridhar is a consultant for Allergan, Alimera Science, and Alcon Laboratories.